Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

28.45 +1.48 (+5.47%)
Streaming Delayed Price Updated: 10:08 AM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
From Law Offices of Howard G. Smith
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
TWST INVESTORS: February 10, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
From Lieff Cabraser Heimann & Bernstein, LLP
Via Business Wire
4 Analysts Have This to Say About Twist Bioscience
 
Via Benzinga
Why Twist Bioscience Stock Is Crashing This Week
Investors were spooked by a short-seller's allegations. 
Via The Motley Fool
Twist Bioscience's Earnings: A Preview
 
Via Benzinga
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Twist Bioscience Corporation (TWST)
From Robbins LLP
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Twist Bioscience Corporation (TWST) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Twist Bioscience Corporation (TWST) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
TWIST ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Twist Bioscience Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Twist Bioscience Corporation (TWST) Investors
From Law Offices of Howard G. Smith
Via Business Wire
EQUITY NOTICE: Rosen Law Firm Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – TWST
From The Rosen Law Firm, P.A.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating PROG, Fox, Instil, and Twist and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Announces the Firm Has Filed a Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Twist Bioscience Corporation Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – TWST
From The Rosen Law Firm, P.A.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating F45, Twist, DLocal, and Provident and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Investors of Twist Bioscience Corporation (NASDAQ: TWST)
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
NASDAQ:TWST Investor Notice: Investigation over Possible Securities Laws Violations by Twist Bioscience Corporation
San Diego, CA -- (SBWIRE) -- 12/07/2022 -- An investigation was announced for investors of Twist Bioscience Corporation (NASDAQ:TWST) shares over potential securities laws violations by Twist... 
Via SBWire
Bragar Eagel & Squire, P.C. Is Investigating Veru, Twist, and Leidos and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
5 Stock Picks For November From Benzinga's Most Accurate Analysts
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes... 
Via Benzinga
Wall Street's Analyst Just Said On Dell Technologies; Here Are Other Picks For Last Week From Top Analysts
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes... 
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Veru, Twist, Leidos, and DLocal and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference
From Twist Bioscience Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Fox, Instil, Veru, and Twist and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
NIO To Surge Around 105%? Plus Keybanc Predicts $165 For This Stock
Keybanc raised the price target on AMETEK, Inc. (NYSE: AME) from $145 to $165. Keybanc analyst Steve Barger maintained an Overweight rating on the stock. AMETEK shares rose 0.9% to close at $139.32 on... 
Via Benzinga
ConocoPhillips To Plunge Over 11%? Plus This Analyst Slashes PT On LiveOne By 25%
  Societe Generale boosted the price target on ConocoPhillips (NYSE: COP) from $106 to $114. ConocoPhillips shares fell 2% to close at $128.59 on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Earnings Scheduled For November 18, 2022
Companies Reporting Before The Bell • So-Young Intl (NASDAQ:SY) is estimated to report quarterly earnings at $0.14 per share on revenue of $62.46 million. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.